POSSIBILITIES OF MODERN THERAPY OF LIVER CIRRHOSIS AND TYPE 2 HEPATORENAL SYNDROME

Abstract

Hepatorenal syndrome (HRS) is a severe complication that occurs in patients with cirrhosis of the liver (LC), characterized by clinical manifestations of renal failure (RF). Type 2 HRS is observed in patients with severe ascites that are refractory to diuretics. The average survival time of patients with type 2 HRS is 6 months. The laboratory criteria for type 2 HRS are the level of creatinine in the blood serum (above 150 mmol/l), characterized by a high plasma content of renin, aldosterone and antidiuretic hormone. Kidney failure develops slowly .